1. Home
  2. FEIM vs CERS Comparison

FEIM vs CERS Comparison

Compare FEIM & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEIM
  • CERS
  • Stock Information
  • Founded
  • FEIM 1961
  • CERS 1991
  • Country
  • FEIM United States
  • CERS United States
  • Employees
  • FEIM 226
  • CERS N/A
  • Industry
  • FEIM Electrical Products
  • CERS EDP Services
  • Sector
  • FEIM Industrials
  • CERS Technology
  • Exchange
  • FEIM Nasdaq
  • CERS Nasdaq
  • Market Cap
  • FEIM 291.0M
  • CERS 265.7M
  • IPO Year
  • FEIM N/A
  • CERS 1997
  • Fundamental
  • Price
  • FEIM $29.76
  • CERS $1.23
  • Analyst Decision
  • FEIM
  • CERS Strong Buy
  • Analyst Count
  • FEIM 0
  • CERS 2
  • Target Price
  • FEIM N/A
  • CERS $3.50
  • AVG Volume (30 Days)
  • FEIM 482.0K
  • CERS 960.9K
  • Earning Date
  • FEIM 09-09-2025
  • CERS 08-05-2025
  • Dividend Yield
  • FEIM N/A
  • CERS N/A
  • EPS Growth
  • FEIM 316.95
  • CERS N/A
  • EPS
  • FEIM 2.46
  • CERS N/A
  • Revenue
  • FEIM $69,811,000.00
  • CERS $192,510,000.00
  • Revenue This Year
  • FEIM $12.60
  • CERS $24.95
  • Revenue Next Year
  • FEIM $19.17
  • CERS $11.88
  • P/E Ratio
  • FEIM $11.45
  • CERS N/A
  • Revenue Growth
  • FEIM 26.30
  • CERS 13.25
  • 52 Week Low
  • FEIM $11.51
  • CERS $1.12
  • 52 Week High
  • FEIM $30.06
  • CERS $2.39
  • Technical
  • Relative Strength Index (RSI)
  • FEIM 65.60
  • CERS 37.72
  • Support Level
  • FEIM $25.88
  • CERS $1.22
  • Resistance Level
  • FEIM $30.39
  • CERS $1.36
  • Average True Range (ATR)
  • FEIM 2.03
  • CERS 0.07
  • MACD
  • FEIM 0.23
  • CERS -0.01
  • Stochastic Oscillator
  • FEIM 81.99
  • CERS 6.00

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: